70%Confidence
0Views
FDASource
2026-03-17Date
Summary
Kirkman's Vasocaine spray recall due to unsupported expiry dates reveals inadequate stability testing practices, potentially affecting other products in their portfolio and triggering broader regulatory review. This topical anesthetic recall creates opportunity for competitors in the veterinary and dental markets.
Actionable: Verify expiry dating practices for all topical pharmaceutical products and consider alternative lidocaine spray suppliers.
AI Confidence: 70%
Data Points
firmHTO Nevada Inc. dba Kirkman
classificationClass II
statusOngoing
distributionNationwide within the U.S
productFIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-01
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now